HybridAR
On sale on the US market (according to the DSLD)
Hybrid Remedies, food supplement from the US market
HybridAR (Hybrid Remedies), a food supplement au code-barres 856396003046, is described by its US market label. If sold in France, it would be subject to 2 points of French or European regulation, detailed below. The formula sold in Europe under the same name may differ.
Official label. Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels, retrieved 27 October 2026.
Source: NIH Office of Dietary Supplements, Dietary Supplement Label Database (CC0); US market labels.
If this product were sold in France
- À vérifier
Apigenin is listed in the Novel Food Catalogue as a novel food not yet authorised in the European Union: in the form covered by the entry, it should not be sold until authorised. The catalogue is informative; a declaration in France is not an authorisation.
Source: Novel Food Catalogue (status of products under Regulation (EU) 2015/2283), POL-NF-15347.
- Conditions légales
Andrographis paniculata (Burm. f.) Nees: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
Source: French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, arrêté du 24 juin 2014, annexe I.
A daily dose is calculated only if the label gives the maximum number of servings and a unit of mass (or international units for vitamin D). Quantities come from the label, not an analysis. In the United States, the label presents this product as a ‘dietary supplement’; in France, a product of this type may belong to another category (a sports powder, for example), and maximum food supplement doses do not apply to it.
Label composition
- Brand
- Hybrid Remedies
- Barcode
- 856396003046
- Form
- Capsule
- One serving
- 2 capsules
- Servings
- up to 1 serving per day
- Other ingredients (in English, as written)
- Cellulose, Microcrystalline Cellulose, Brown Rice, Maltodextrin
| Ingredient (as written, in English) | Category | Per serving |
|---|---|---|
| Proprietary Blend | Blend | 316 mg |
| Echinacea Root Extract | Plant | not stated |
| Andrographis paniculata (Andrographis paniculata) | Plant | not stated |
| Panax ginseng Root Extract | Plant | not stated |
| Butterbur Root Extract | Plant | not stated |
| Rosemarinic Acid | Other substance | not stated |
| Quercetin Dihydrate | Other substance | not stated |
| Apigenin | Other substance | not stated |
Displayed label: Official label. Labels on the market are prioritised, followed by the most recent for the same status.
Other versions of this label
The differences below describe each other version relative to the label shown on this page. They concern active ingredient rows and quantities per serving as written. Missing quantities are not estimated and different units are not converted. Dates refer to entry into DSLD, not necessarily to a formula change.
Official label: HybridAR
Entered into DSLD on 13 December 2022. On sale on the US market (according to the DSLD).- Same quantity, different name: Echinacea purpurea root extract in this version; Echinacea Root Extract on the displayed label (quantity not stated)
This information reproduces the US label recorded by the US National Institutes of Health (NIH). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
List declared on (register: Dietary Supplement Label Database (DSLD), US National Institutes of Health: current and off-market labels).
Brand : Hybrid Remedies
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “HybridAR (Hybrid Remedies): composition and French regulation”, https://compoatlas.com/en/supplements/us-labels/856396003046-hybridar-hybrid-remedies, updated 23 April 2024.